中恒集团(600252.SH)拟公开征集莱美药业23.43%股份受让方转让价不低于4.42元/股

智通财经12-12

智通财经APP讯，中恒集团(600252.SH)发布公告，公司拟通过公开征集受让方的方式协议转让持有的重庆莱美药业股份有限公司(简称“莱美药业”)2.47亿股无限售条件流通股A股股票，占莱美药业总股本的23.43%，转让价格不低于提示性公告日前30个交易日的每日加权平均价格的算术平均值即4.42元/股。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2490805959?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-12 18:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2490805959","market":"sh","top_or_hot":-1,"title":"中恒集团(600252.SH)拟公开征集莱美药业23.43%股份受让方 转让价不低于4.42元/股","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/600252\">中恒集团</a>(600252.SH)发布公告，公司拟通过公开征集受让方的方式协议转让持有的重庆<a href=\"https://laohu8.com/S/300006\">莱美药业</a>股份有限公司(简称“莱美药业”)2.47亿股无限售条件流通股A股股票，占莱美药业总股本的23.43%，转让价格不低于提示性公告日前30个交易日的每日加权平均价格的算术平均值即4.42元/股。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中恒集团(600252.SH)拟公开征集莱美药业23.43%股份受让方 转让价不低于4.42元/股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中恒集团(600252.SH)拟公开征集莱美药业23.43%股份受让方 转让价不低于4.42元/股\n</h2>\n\n<h4 class=\"meta\">\n\n<p class=\"head\">\n<strong class=\"h-name small\">智通财经</strong><span class=\"h-time small\">2024-12-12 18:44</span>\n</p>\n\n</h4>\n\n</header>\n<article>\n<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/600252\">中恒集团</a>(600252.SH)发布公告，公司拟通过公开征集受让方的方式协议转让持有的重庆<a href=\"https://laohu8.com/S/300006\">莱美药业</a>股份有限公司(简称“莱美药业”)2.47亿股无限售条件流通股A股股票，占莱美药业总股本的23.43%，转让价格不低于提示性公告日前30个交易日的每日加权平均价格的算术平均值即4.42元/股。</p></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"http://www.zhitongcaijing.com/content/detail/1224138.html\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0015","symbol_name":"沪股通50","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1224138.html","article_id":"2490805959","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2490805959","pubTimestamp":1734000248,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，中恒集团(600252.SH)发布公告，公司拟通过公开征集受让方的方式协议转让持有的重庆莱美药业股份有限公司(简称“莱美药业”)2.47亿股无限售条件流通股A股股票，占莱美药业总股本的23.43%，转让价格不低于提示性公告日前30个交易日的每日加权平均价格的算术平均值即4.42元/股。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300006":"莱美药业","600252":"中恒集团","BK0015":"沪股通50","BK0070":"员工持股","BK0188":"融资融券","BK0028":"国家队","BK0239":"医药制造","BK0012":"证金概念","BK0077":"质押式回购"},"translate_title":"Zhongheng Group (600252. SH) plans to publicly solicit 23.43% of the shares of Laimei Pharmaceutical. The transfer price of the transferee is not less than 4.42 yuan/share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300006":1,"600252":1},"content_text":"智通财经APP讯，中恒集团(600252.SH)发布公告，公司拟通过公开征集受让方的方式协议转让持有的重庆莱美药业股份有限公司(简称“莱美药业”)2.47亿股无限售条件流通股A股股票，占莱美药业总股本的23.43%，转让价格不低于提示性公告日前30个交易日的每日加权平均价格的算术平均值即4.42元/股。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2490805959"}

中恒集团(600252.SH)拟公开征集莱美药业23.43%股份受让方 转让价不低于4.42元/股

精彩评论

中恒集团(600252.SH)拟公开征集莱美药业23.43%股份受让方转让价不低于4.42元/股